Protease-activated receptors in hemostasis, thrombosis and vascular biology

被引:801
作者
Coughlin, SR
机构
[1] Univ Calif San Francisco, Dept Med, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA
关键词
D O I
10.1111/j.1538-7836.2005.01377.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The coagulation cascade and protease-activated receptors (PARs) together provide an elegant mechanism that links mechanical information in the form of tissue injury to cellular responses. These receptors appear to largely account for the cellular effects of thrombin and can mediate signaling to other trypsin-like proteases. An important role for PARs in hemostasis and thrombosis is established in animal models, and studies in knockout mice and nonhuman primates raise the question of whether PAR inhibition might offer an appealing new approach to the prevention and treatment of thrombosis. PARs may also trigger inflammatory responses to tissue injury. For example, PAR activation on endothelial cells and perhaps sensory afferents can trigger local accumulation of leukocytes and platelets and transudation of plasma. However, panoply of signaling systems and cell types orchestrates inflammatory responses, and efforts to define the relative importance and roles of PARs in various inflammatory processes are just beginning. Lastly, roles for PARs in blood vessel formation and other processes during embryonic development are emerging, and whether these reflect new roles for the coagulation cascade and/or PAR signaling to other proteases remains to be explored.
引用
收藏
页码:1800 / 1814
页数:15
相关论文
共 181 条
  • [1] Thrombin primes responsiveness of selective chemoattractant receptors at a site distal to G protein activation
    Ali, H
    Tomhave, D
    Richardson, RM
    Haribabu, B
    Snyderman, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) : 3200 - 3206
  • [2] Andrade-Gordon P, 2001, J PHARMACOL EXP THER, V298, P34
  • [3] Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor
    Andrade-Gordon, P
    Mayanoff, BE
    Derian, CK
    Zhang, HC
    Addo, MF
    Darrow, AL
    Eckardt, AJ
    Hoekstra, WJ
    McComsey, DF
    Oksenberg, D
    Reynolds, EE
    Santulli, RJ
    Scarborough, RM
    Smith, CE
    White, KB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) : 12257 - 12262
  • [4] The glycoprotein Ib-IX-V complex in platelet adhesion and signaling
    Andrews, RK
    Shen, Y
    Gardiner, EE
    Dong, JF
    López, JA
    Berndt, MC
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) : 357 - 364
  • [5] THE THROMBIN RECEPTOR EXTRACELLULAR DOMAIN CONTAINS SITES CRUCIAL FOR PEPTIDE LIGAND INDUCED ACTIVATION
    BAHOU, WF
    COLLER, BS
    POTTER, CL
    NORTON, KJ
    KUTOK, JL
    GOLIGORSKY, MS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) : 1405 - 1413
  • [6] Barr AJ, 1997, J BIOL CHEM, V272, P2223
  • [7] Development of potent thrombin receptor antagonist peptides
    Bernatowicz, MS
    Klimas, CE
    Hartl, KS
    Peluso, M
    Allegretto, NJ
    Seiler, SM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (25) : 4879 - 4887
  • [8] INDUCIBLE ENDOTHELIAL FUNCTIONS IN INFLAMMATION AND COAGULATION
    BEVILACQUA, MP
    GIMBRONE, MA
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1987, 13 (04) : 425 - 433
  • [9] TRANSITION OF BOVINE TRYPSINOGEN TO A TRYPSIN-LIKE STATE UPON STRONG LIGAND-BINDING - REFINED CRYSTAL-STRUCTURES OF BOVINE TRYPSINOGEN-PANCREATIC TRYPSIN-INHIBITOR COMPLEX AND OF ITS TERNARY COMPLEX WITH ILE-VAL AT 1.9 A RESOLUTION
    BODE, W
    SCHWAGER, P
    HUBER, R
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1978, 118 (01) : 99 - 112
  • [10] BRASS LF, 1992, J BIOL CHEM, V267, P13795